supraspinatous tear Platelet rich plasma,
Conditions
Interventions
Triamcinolone acetate 40 mg,Platelet rich plasma
convention,PRP
Sponsors
faculty of medicine, Chulalongkorn University
Department of anesthesia,
faculty of medicine,
Chulalongkorn University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-80 years old, no serious systemic diseases such as uncontrolled diabetes, hyperthyroidism, or end-stage renal failure 2. Partial supraspinatus tendon tears confirmed with magnetic resonance imaging (MRI) Partial supraspinatus tear was defined as a tendon disruption that did not involve the entire thickness of the tendon.19 3. Ability to participate for a minimum follow-up period of six months
Exclusion criteria
Exclusion criteria: 1. Severe arthritis or other complications related to supraspinatus tears, such as generalized inflammatory arthritis, infection 2. Malignancy 3. Coagulopathy 4. Immunocompromised patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain 1,6 month visual analogue pain score | — |
Secondary
| Measure | Time frame |
|---|---|
| shoulder function 1,6 month Oxford Shoulder Score | — |
Countries
Thailand
Contacts
Public Contactmarvin thepsoparn
Department of anesthesia, Chulalongkorn University
Outcome results
None listed